Talis Biomedical Corporation (TLIS)
NASDAQ: TLIS · IEX Real-Time Price · USD
8.74
+0.07 (0.81%)
At close: Jul 19, 2024, 4:00 PM
8.57
-0.17 (-1.95%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Talis Biomedical Market Cap
Talis Biomedical has a market cap or net worth of $15.93 million as of July 22, 2024. Its market cap has decreased by -42.71% in one year.
Market Cap
15.93M
Enterprise Value
-35.17M
1-Year Change
-42.71%
Ranking
Category
Stock Price
$8.74
Market Cap Chart
Since the IPO on February 12, 2021, Talis Biomedical's market cap has decreased from $853.50M to $15.93M, a decrease of -98.13%. That is a compound annual growth rate of -68.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 33.30M | 17.25% |
| Dec 29, 2023 | 28.40M | 12.70% |
| Dec 30, 2022 | 25.20M | -88.81% |
| Dec 31, 2021 | 225.20M | -73.61% |
| Feb 12, 2021 | 853.50M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Microbot Medical | 16.76M |
| Aytu BioPharma | 16.66M |
| PharmaCyte Biotech | 16.57M |
| Chemomab Therapeutics | 16.49M |
| China Jo-Jo Drugstores | 16.04M |
| BIMI International Medical | 15.65M |
| Edesa Biotech | 15.28M |
| Galecto | 15.07M |